P-007: HYDROXYUREA FOR THE MANAGEMENT OF SICKLE CELL DISEASE IN LOW- AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW (2000–2022)

• TSHILOLO L.,
• MARFO K.,
• ADISON F.,
• KHAN S.,
• PAINTSIL V.

Affiliations

TSHILOLO L.

1 Centre Hospitalier Mère-Enfant, Kinshasa, REPUBLIC OF THE CONGO

MARFO K.

3 Novartis Pharma AG, Switzerland, Basel, SWITZERLAND

ADISON F.

5 Novartis Pharmaceuticals Inc., United states, Cambridge, UNITED STATES

KHAN S.

4 Novartis Healthcare Pvt Ltd., Hyderabad, INDIA

PAINTSIL V.

2 Kwame Nkrumah University of Science and Technology/Komfo Anokye Teaching Hospital, Kumasi, GHANA